Susan Orr
Direktor/Vorstandsmitglied bei OPTHEA LIMITED
Vermögen: - $ am 31.05.2024
Aktive Positionen von Susan Orr
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OPTHEA LIMITED | Direktor/Vorstandsmitglied | 21.04.2022 | - |
Claris Biotherapeutics, Inc.
 Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | Geschäftsführer | - | - |
| Retina Global | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Susan Orr
Ehemalige bekannte Positionen von Susan Orr
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Notal Vision Ltd.
 Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Vorstandsvorsitzender | 01.01.2019 | 23.10.2019 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.07.2016 | 01.01.2019 |
Ausbildung von Susan Orr
| The University of Waterloo | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Australien | 2 |
| Kanada | 2 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Notal Vision Ltd.
Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Health Services |
Claris Biotherapeutics, Inc.
Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | Health Technology |
| Retina Global |
